# The Image Clarity Paradox: Higher CZT SPECT Contrast Does Not Always Translate to Diagnostic Accuracy for Alzheimer’s Disease

**Authors:** Kiyotaka Nemoto, Bryan J. Mathis, Akemi Iwasaka, Kenjiro Nakayama, Tomohiro Kaneta, Tetsuaki Arai

PMC · DOI: 10.3390/tomography11060061 · Tomography · 2025-05-25

## TL;DR

Higher image contrast from CZT SPECT does not improve Alzheimer's diagnosis accuracy, suggesting better training is needed for clinicians.

## Contribution

Demonstrates that improved SPECT image quality does not automatically enhance diagnostic accuracy for Alzheimer’s disease.

## Key findings

- CZT SPECT provides higher gray matter/white matter contrast than eCAM SPECT.
- Diagnostic accuracy for Alzheimer’s disease decreased for both a psychiatrist and a radiologist using CZT SPECT.
- Specialized training is needed to interpret higher-resolution CZT SPECT images effectively.

## Abstract

Background: Recent advances in single-photon emission computed tomography (SPECT) technology, particularly cadmium–zinc–telluride (CZT) detectors, have improved spatial resolution and contrast in cerebral blood flow imaging. This study aimed to investigate whether these improvements translate to enhanced diagnostic accuracy for Alzheimer’s disease (AD). Methods: We compared conventional SPECT (eCAM) with CZT SPECT in 29 patients (mean age 60.9 ± 17.6 years, 69% female) with suspected neurodegenerative diseases. Results: Gray matter/white matter contrast was significantly higher in CZT SPECT compared to eCAM (1.615 ± 0.096 vs. 1.458 ± 0.068, p < 0.001). However, diagnostic accuracy for AD did not improve with CZT SPECT. For the participating psychiatrist, sensitivity decreased from 0.750 (eCAM) to 0.625 (CZT), while for the radiologist, specificity dropped from 0.571 (eCAM) to 0.429 (CZT). Overall accuracy slightly decreased for both readers. Conclusions: These findings suggest that while CZT SPECT offers superior image quality, it may not immediately translate to improved diagnostic accuracy for AD. The study highlights the importance of specialized training for clinicians in interpreting higher-resolution CZT SPECT images to fully leverage their potential in neurodegenerative disease diagnosis. Future research should focus on developing standardized training protocols and larger, multi-center studies to validate these findings.

## Linked entities

- **Diseases:** Alzheimer’s disease (MONDO:0004975)

## Full-text entities

- **Diseases:** AD (MESH:D000544), neurodegenerative disease (MESH:D019636)
- **Chemicals:** CZT (MESH:C474490)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12196972/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12196972/full.md

## References

20 references — full list in the complete paper: https://tomesphere.com/paper/PMC12196972/full.md

---
Source: https://tomesphere.com/paper/PMC12196972